Orthofix Medical Inc.
Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other…
1D
-2.2%
1W
+2.3%
1M
+5.4%
6M
-26.2%
YTD
-38.1%
1Y
-38.5%
2Y
-41.4%
5Y
-74.1%
10Y
-76.3%
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~50% stronger price swings than usual
PRICE TARGET LOW
US$12.00
CONSENSUS
US$13.40
MEDIAN
US$13.00
PRICE TARGET HIGH
US$15.00
0
STRONG BUY
7
BUY
9
HOLD
1
SELL
0
STRONG SELL
17
TOTAL · Hold
As of: 10/08/2026
P/E
-6.11
P/B
0.89
EV/EBITDA
5.56
RETURN ON EQUITY
-3.7%
NET MARGIN
-7.5%
DEBT/EQUITY
0.55
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
100.0%
FLOAT SHARES
40,407,969
AVG. DAILY VOLUME (30D)
408,631
Fisher Patrick
Juniper Investment Company, LLC
Juniper Investment Company, LLC
Fisher Patrick
Fisher Patrick
Orthofix Medical Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Massimo Calafiore, the company employs around 1,605 people.
The IPO was on 24/04/1992; the stock trades on NASDAQ under the ticker OFIX.
17 analysts rate the stock, the consensus is Hold (as of 10/08/2026).
The average price target is US$13.40, ranging from US$12.00 to US$15.00, with a median of US$13.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 50% stronger than usual.
No, Orthofix Medical currently does not pay a dividend.
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
Clicking "Analyze stock" lets five strategies assess Orthofix Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.